Travere Therapeutics officer proposes $903K sale

Sandra Calvin also reported a February 3, 2026 sale of 4,333 common shares for gross proceeds of $139,177.16.

Accepted by SEC EDGAR 04/14/2026 - 04:02 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Travere Therapeutics, Inc. (TVTX) is identified as the issuer for Officer Sandra Calvin’s proposed sale of 21,977 common shares, with an aggregate market value of $902,595.39 and an approximate sale date of April 14, 2026. Morgan Stanley Smith Barney LLC is listed as the broker. The notice gives June 10, 2025 as the date of plan adoption or instruction, if relying on Rule 10b5-1. The shares listed for sale were acquired through restricted stock awards of 1,263 shares on January 21, 2025 and 5,464 shares on January 31, 2025, plus a 15,250-share stock option exercise on April 14, 2026. Calvin also reported selling 4,333 common shares on February 3, 2026, for gross proceeds of $139,177.16 during the preceding three months.

Key Figures

Common shares proposed for sale: 21,977 shares Aggregate market value: $902,595.39 Common shares outstanding: 92,241,550 shares +2 more

5 metrics

Common shares proposed for sale 21,977 shares Approximate sale date: April 14, 2026

Aggregate market value $902,595.39 For the proposed sale

Common shares outstanding 92,241,550 shares Reported in the securities information

Common shares sold 4,333 shares Sale reported for February 3, 2026

Gross proceeds $139,177.16 From the February 3, 2026 sale

Key Terms

Rule 10b5-1, Restricted Stock, Stock Option Exercise, Aggregate Market Value

4 terms

Rule 10b5-1 regulatory

"If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Restricted Stock financial

"Nature of Acquisition Transaction: Restricted Stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Stock Option Exercise financial

"Nature of Acquisition Transaction: Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TVTX shares did Sandra Calvin propose to sell?

Officer Sandra Calvin’s notice lists 21,977 common shares for sale, with an aggregate market value of $902,595.39 and an approximate sale date of April 14, 2026. Morgan Stanley Smith Barney LLC is named as the broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001882909
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	SANDRA CALVIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21977	902595.39	92241550	04/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/21/2025	Restricted Stock	Issuer			1263	01/21/2025	Not Applicable
Common	01/31/2025	Restricted Stock	Issuer			5464	01/31/2025	Not Applicable
Common	04/14/2026	Stock Option Exercise	Issuer			15250	04/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SANDRA CALVIN 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	02/03/2026	4333	139177.16

144: Remarks and Signature

Remarks
Date of Notice	04/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sandra Louise Calvin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)